Table 2

Number of enhancing lesions on baseline MRI and newly active lesions on six months of follow up scans in RRMS patient

Patient No		Baseline scan		Months of follow up		AII		AIII
Patient No		Baseline scan		1	2	AII		AIII		3	4	5	6
1	4	0	0	0	0	0	0	0	0
2	7	0	4	3	5	10	17	83	39
3	0	0	0	2	0	13	6	50	21
4	4	2	1	2	7	4	4	100	20
5	0	0	0	0	0	0	0	0	0
6	0	0	0	0	0	0	0	0	0
7	0	1	1	0	0	1	0	50	3
8	0	0	0	0	0	0	0	0	0
9	1	4	2	2	0	0	1	67	9
10	1	0	1	1	3	1	0	67	6
11	5	6	4	4	7	9	7	100	37
12	0	0	0	0	0	0	0	0	0
13	0	0	0	0	1	0	0	17	1
14	4	2	1	0	0	0	0	33	3
15	2	2	2	1	2	4	1	100	12
16	0	4	1	4	0	0	0	50	9
17	1	1	0	0	0	1	0	33	2
18	0	0	0	0	0	0	0	0	0
19	2	2	0	0	0	0	0	17	2
20	0	0	2	2	2	0	0	50	6
21	0	0	5	1	1	1	0	67	8
22	0	1	0	7	5	11	12	83	36
23	0	0	0	1	2	0	0	33	3
24	1	1	1	0	1	0	1	67	4
25	5	4	0	1	0	2	0	50	7
26	0	2	0	0	0	0	0	17	2
27	3	11	5	3	2	1	0	83	22
28	0	1	1	1	0	0	0	50	3
29	0	3	0	0	1	1	2	67	7
30	3	2	0	0	0	1	1	50	4
31	1	1	1	1	3	0	1	83	7

AII = the percentage of scans (per patient) on which newly active lesions were seen.
AIII = the total number of active lesions seen during the study period.